LION TCR
They are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia. For the past decade, they have accumulated expertise covering the entire product development process, ranging from basic research, T cell engineering and development, and preclinical/clinical assessment. Led by industry and academic experts from their base in Singapore, they are dedicated to the commercialization and continued development of their immunotherapy products.
LION TCR
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2015-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.liontcr.com
Total Employee:
1+
Status:
Active
Contact:
+65 6586 9633
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Atavistik Bio
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.
Calimmune
Calimmune is a clinical-stage gene therapy company.
CytoNiche
CytoNiche is a 3D bionic cell technology company.
ImmuneID
ImmuneID is a precision immunology company.
Ionova Life Science
Ionova Life Science IS a biotech company.
KOTAI Biotechnologies
KOTAI Biotechnologies is a biotechnology company.
No-Antibiotics
No-Antibiotics is a phage drug developer company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Origin Agritech
Origin Agritech is a leading agricultural biotechnology company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Topokine Therapeutics
Topokine is a Boston-based, clinical-stage biotechnology company.
Tychan
Tychan is a clinical-stage biotechnology company.
X-ZELL
Democratising cancer diagnostics by bringing digital single-cell analytics into routine cytology
Current Employees Featured
Founder
Investors List
Westlake Venture Partners
Westlake Venture Partners investment in Series A - Lion TCR
Yashang Capital
Yashang Capital investment in Series A - Lion TCR
Official Site Inspections
http://www.liontcr.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Lion TCR"
LionTCR | Home
Nov 14, 2024ย ยท At Lion TCR, over a decadeโs worth of basic research, product engineering and development, and pre-clinical/clinical assessment have culminated in our leading product that โฆSee details»
LionTCR | Company
Lion TCR is a clinical-stage biotechnology company dedicated to the continued development and commercialization of our TCR-T therapy. Prof Antonio Bertoletti is named top 0.1% Hepatitis B Expert in the World over the past 10 years โฆSee details»
Lion TCR - Crunchbase Company Profile & Funding
View contacts for Lion TCR to access new leads and connect with decision-makers. They are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia.See details»
Lion TCR Company Profile 2024: Valuation, Funding & Investors
Developer of T-cell receptor therapy designed to improve therapy against cancers and life-threatening infectious diseases.See details»
Lion TCR - Overview, News & Similar companies | ZoomInfo.com
Jun 27, 2023ย ยท View Lion TCR (www.liontcr.com) location in Central Singapore, Singapore , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Resources - LionTCR
Nov 14, 2024ย ยท LionTCR is dedicated to the development of our proprietary novel cancer immunotherapy products.See details»
Lion TCR - LinkedIn
At Lion TCR, our dedication extends beyond advancing our flagship product for advanced liver cancer. We're committed to addressing the challenges of chronic hepatitis B, early and mid โฆSee details»
Lion TCR Summary - Craft
Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. The Company's lead product targets hepatitis B virus โฆSee details»
Lion TCR - VentureRadar
Website: http://www.liontcr.com/ We are a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia.See details»
Lion TCR - VentureRadar
Website: http://www.liontcr.com/ Develops TCR-T cell therapy for cancers and life-threatening infectious diseases in Asia, with a focus on hepatitis B virus-related hepatocellular carcinoma โฆSee details»
Lion TCR - Products, Competitors, Financials, Employees, โฆ
Lion TCR focuses on the development of immunotherapy treatments within the biotechnology sector. The company offers T cell receptor (TCR)-T cell therapy to target viral infections and โฆSee details»
Lion TCR Secures USD 40 million Series B2 Financing, โฆ
Jun 27, 2023ย ยท SINGAPORE and GUANGZHOU, China, June 27, 2023 /PRNewswire/ -- 27 June 2023, Lion TCR, a clinical-stage T-cell immunotherapy company, is thrilled to announce the โฆSee details»
Contact - LionTCR
Find us at any of our global offices.See details»
The Formula Behind Lion TCR's Lifechanging Cancer Therapy - 00.
Nov 18, 2022ย ยท To address this unmet medical need, Lion TCR has developed an autologous T-cell immunotherapy against Hep B-associated liver cancer and chronic Hep B. Spun off from โฆSee details»
Lion TCR CEO and Key Executive Team | Craft.co
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API. Lion TCR's Co-Founder & Chairman is Lietao Li. See the full leadership โฆSee details»
Technology - LionTCR
Our TCR-T cell therapy harnesses the patientโs own immune system to fight against viral infections and related cancers.See details»
Immunotherapy company Lion TCR raises US$40 million in ... - ๅ โฆ
Jun 27, 2023ย ยท Lion TCR, which has its China headquarters at the International Biomedical Innovation Center, is looking to develop treatments that target various solid cancers and โฆSee details»
Lion TCR Receives FDA Fast Track Designation for its HBV-specific โฆ
Dec 23, 2021ย ยท SINGAPORE and GUANGZHOU, China and LOS ANGELES, Dec. 23, 2021 /PRNewswire/ -- Lion TCR Pte Ltd today announced that it has received Fast Track โฆSee details»
Copy of LionTCR
Aug 28, 2017ย ยท Lion TCR obtained the global exclusive transfer of the TCR-T cell immunotherapy technology from A*STAR ETPL. Lion TCRโs technology was developed based on the research โฆSee details»
Pipeline - LionTCR
Our lead product, LioCyx-M, an autologous T-cell product transfected with mRNA encoding HBV antigen-specific TCR, has been used clinically for the treatment of HBV-related liver cancer โฆSee details»